Duration of Blockade of Peripheral Nerves With Bupivacaine Depending of the Adjuvants

NCT ID: NCT04498923

Last Updated: 2022-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

68 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2022-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of the investigator's study is to propose combination of local anesthetics and adjuvants that provides both adequate anesthesia during surgery and prolonged post-operative analgesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Peripheral nerve plexuses blocks are performing as a component of analgesia in patients undergoing orthopedic surgery on the upper or lower extremities. Patients are divided into two groups depending on the adjuvant to the local anesthetic: 1st group - patients whose blockade is performed with a solution of bupivacaine 0.375% together with dexamethasone 0.02%; Group 2 - patients whose blockade is performed with a solution of bupivacaine 0.375% together with dexamethasone 0.02% and epinephrine 0.00018%. The duration of the blockade is estimated by puncturing the skin with a needle. The intensity of pain is assessed at 6, 12, 24 and 36 hours after blockade using Visual analog scale (VAS). The amount of narcotic anesthetic used in the postoperative period is also recorded. In addition, patients underwent electromyography of the innervation area of the blocked nerve before the surgery and 24 and 36 hours after surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain Peripheral Neuropathy Fractures of the Upper Limb Fracture of the Lower Limb (Except Hip), Initial Encounter Intraoperative Hypotension Intraoperative Hypertension Pain Syndrome Anesthesia Anesthesia, Local Local Anesthetic Systemic Toxicity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bupivacaine with dexamethasone

Ultrasound guided peripheral nerve block for upper or lower extremity was performed before orthopedic surgery using neurostimulator.

Twenty milliliters solution of bupivacaine 0,375% with dexamethasone was injected for one plexus or peripheral nerve.

Bupivacaine, dexamethasone, epinephrine

Intervention Type DRUG

Bupivacaine 75 mg, dexamethasone 4 mg, epinephrine 0,18 mg

Bupivacaine with dexamethasone and epinephrine

Ultrasound guided peripheral nerve block for upper or lower extremity was performed before orthopedic surgery using neurostimulator.

Twenty milliliters solution of bupivacaine 0,375% with dexamethasone 0,02% and epinephrine 0,00018% was injected for one plexus or peripheral nerve.

Bupivacaine, dexamethasone, epinephrine

Intervention Type DRUG

Bupivacaine 75 mg, dexamethasone 4 mg, epinephrine 0,18 mg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine, dexamethasone, epinephrine

Bupivacaine 75 mg, dexamethasone 4 mg, epinephrine 0,18 mg

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients undergoing upper or lower extremity orthopedic surgery

Exclusion Criteria

* diabetes mellitus;
* diseases of the peripheral nerv system
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lviv National Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maksym Barsa

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maksym Barsa

Role: PRINCIPAL_INVESTIGATOR

Сlinical resident

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rivne Oblast State Hospital

Rivne, Rivne Oblast, Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ukraine

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LNMY-FPGE- ANESTHESIOLOGY-DBBA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Liposomal Bupivacaine With Dexamethasone for Foot Surgery
NCT06465992 ENROLLING_BY_INVITATION PHASE4